呼吸

慢性阻塞性肺疾病评估试验作为预测重度慢性阻塞性肺疾病急性加重的预测因素

作者:高翠歌 编译 来源:金宝搏网站登录技巧 日期:2016-05-22
导读

         慢性阻塞性肺疾病评估试验作为预测重度慢性阻塞性肺疾病急性加重的预测因素

关键字:  COPD | 加重期 | CAT 

The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations

Patricia García-Sidro, Elsa Naval, Carlos Martinez Rivera, Marc Bonnin-Vilaplana, Juan Luís Garcia-Rivero, Alberto Herrejón, Rosa Malo de Molina, Pedro Jorge Marcos, Sagrario Mayoralas-Alises, Jose Antonio Ros, Manuel Valle, Cristina Esquinas, Miriam Barrecheguren, Marc Miravitllese

Introduction

 

Since exacerbations of chronic obstructive pulmonary disease (COPD) cause both a great impact on the progression of the disease and generate high health expenditures, there is a need to develop tools to evaluate their prognosis.

Method

 

Multicenter, observational, prospective study that evaluated the prognostic utility of the COPD Assessment Test (CAT) in severe exacerbations of COPD. Anthropometric and clinical variables were analyzed: smoking, history of exacerbations during the previous year, drug treatment, degree of baseline dyspnea, comorbidities; laboratory variables at admission (complete blood count, arterial blood gas and biochemistry) and CAT scores in the first 24 h of admission, on the third day, at discharge and at 3 months.

Results

 

We evaluated 106 patients (91 males) with a mean age of 71.1 (SD 9.8 years), mean FEV1 45.2% (14.7%) and average CAT score at admission of 24.7 points (7.1). At three months after discharge, treatment failure was observed in 39 (36.8%) patients: 14 (13.2%) presented an exacerbation without the need for hospital admission, 22 were readmitted (20.8%) and 3 (2.8%) died during follow-up. The three factors associated with increased risk of failure were a reduction less than 4 units in the CAT at discharge compared to admission, lower hemoglobin levels and treatment with domiciliary oxygen.

Conclusions

 

A change of ≤4 points in the CAT score at discharge compared to that obtained at admission due to a severe exacerbation of COPD, helps to predict therapeutic failure such as a new exacerbation, readmission or death in the subsequent three months.

respiratory medicine

December 2015Volume 109, Issue 12, Pages 1546–1552

DOI: http://dx.doi.org/10.1016/j.rmed.2015.10.011 |

分享:

相关文章

评论

我要跟帖
发表
回复 小鸭梨
发表

copyright©金宝搏网站登录技巧 版权所有,未经许可不得复制、转载或镜像

京ICP证120392号  京公网安备110105007198  京ICP备10215607号-1  (京)网药械信息备字(2022)第00160号
//站内统计 //百度统计 //谷歌统计 //站长统计
*我要反馈: 姓    名: 邮    箱:
Baidu
map